Editas Medicine (EDIT) Short Interest Ratio & Short Volume $1.38 +0.05 (+3.36%) As of 02:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Editas Medicine Short Interest DataEditas Medicine (EDIT) has a short interest of 19.15 million shares. This marks a 5.16% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.1, indicating that it would take 7.1 days of the average trading volume of 2.49 million shares to cover all short positions.Current Short Interest19,150,000 sharesPrevious Short Interest18,210,000 sharesChange Vs. Previous Month+5.16%Dollar Volume Sold Short$23.36 millionShort Interest Ratio7.1 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares82,550,000 sharesPercentage of Shares Shorted23.20%Today's Trading Volume672,861 sharesAverage Trading Volume2,492,111 sharesToday's Volume Vs. Average27% Short Selling Editas Medicine? Sign up to receive the latest short interest report for Editas Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEDIT Short Interest Over TimeEDIT Days to Cover Over TimeEDIT Percentage of Float Shorted Over Time Editas Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/202519,150,000 shares $23.36 million +5.2%N/A7.1 $1.22 12/31/202418,210,000 shares $23.13 million +7.6%N/A7 $1.27 12/15/202416,930,000 shares $24.38 million +5.4%N/A6.9 $1.44 11/30/202416,060,000 shares $35.97 million +0.9%N/A7.2 $2.24 11/15/202415,910,000 shares $42.32 million -7.7%N/A7.4 $2.66 10/31/202417,240,000 shares $50.00 million -6.0%N/A8.8 $2.90 10/15/202418,330,000 shares $61.59 million +9.5%N/A9.9 $3.36 9/30/202416,740,000 shares $57.08 million -11.7%N/A9.3 $3.41 9/15/202418,960,000 shares $74.89 million +5.3%N/A10.5 $3.95 8/31/202418,010,000 shares $67.36 million +6.6%N/A9.4 $3.74 Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 8/15/202416,900,000 shares $67.60 million +4.8%N/A8.5 $4.00 7/31/202416,130,000 shares $87.26 million +2.2%N/A7.7 $5.41 7/15/202415,790,000 shares $88.58 million -5.7%N/A7.6 $5.61 6/30/202416,740,000 shares $78.18 million -22.9%N/A8 $4.67 6/15/202421,700,000 shares $109.80 million -1.5%N/A10.6 $5.06 5/31/202422,020,000 shares $114.50 million +6.1%N/A11.7 $5.20 5/15/202420,760,000 shares $124.56 million +1.3%N/A10.3 $6.00 4/30/202420,500,000 shares $106.81 million +9.3%N/A10.3 $5.21 4/15/202418,760,000 shares $114.06 million +14.7%N/A9.8 $6.08 3/31/202416,360,000 shares $121.39 million +17.4%N/A8.9 $7.42 3/15/202413,930,000 shares $113.25 million +3.0%N/A7.5 $8.13 2/29/202413,520,000 shares $136.01 million +7.4%N/A7 $10.06 2/15/202412,590,000 shares $104.62 million +3.1%N/A7.2 $8.31 1/31/202412,210,000 shares $85.84 million -2.2%N/A6.7 $7.03 1/15/202412,480,000 shares $113.19 million -2.4%N/A6.8 $9.07 12/31/202312,790,000 shares $129.56 million -14.6%N/A7 $10.13 12/15/202314,970,000 shares $163.62 million -5.1%N/A7.7 $10.93 11/30/202315,780,000 shares $166.16 million -0.6%N/A8.9 $10.53 11/15/202315,870,000 shares $140.29 million -5.4%N/A9.7 $8.84 10/31/202316,770,000 shares $112.02 million +2.1%N/A11 $6.68 10/15/202316,420,000 shares $115.76 million +2.8%N/A11.2 $7.05 9/30/202315,970,000 shares $124.57 million +5.2%N/A11.1 $7.80 9/15/202315,180,000 shares $127.36 million +4.7%N/A10.8 $8.39 8/31/202314,500,000 shares $129.20 million +0.6%N/A8.1 $8.91 8/15/202314,410,000 shares $126.23 million -6.7%N/A7.5 $8.76 7/31/202315,440,000 shares $135.56 million -0.2%N/A7.5 $8.78 7/15/202315,470,000 shares $133.20 million -20.4%N/A7.4 $8.61 6/30/202319,430,000 shares $159.91 million -5.8%N/A8.6 $8.23 6/15/202320,630,000 shares $191.45 million +0.6%N/A9 $9.28 5/31/202320,500,000 shares $188.19 million +1.3%N/A11 $9.18A new coin is elbowing its way to the top of the crypto world (Ad)With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … 5/15/202320,230,000 shares $202.50 million +7.3%N/A11 $10.01 4/30/202318,860,000 shares $153.90 million -5.5%N/A10.7 $8.16 4/15/202319,950,000 shares $151.42 million +1.5%N/A11.1 $7.59 3/31/202319,650,000 shares $142.46 million -4.8%N/A11.3 $7.25 3/15/202320,640,000 shares $174.00 million +7.7%N/A11.9 $8.43 2/28/202319,160,000 shares $173.21 million -2.6%N/A10 $9.04 2/15/202319,670,000 shares $203.78 million -6.1%N/A10.2 $10.36 1/31/202320,940,000 shares $207.10 million -5.4%N/A10.5 $9.89 1/15/202322,140,000 shares $186.64 million +2.3%N/A11.8 $8.43 12/30/202221,650,000 shares $192.04 million +2.3%N/A12 $8.87 12/15/202221,170,000 shares $211.91 million +7.7%N/A12.3 $10.01 11/30/202219,650,000 shares $208.29 million +4.0%N/A11.7 $10.60 11/15/202218,900,000 shares $246.65 million +2.3%N/A12.1 $13.05 10/31/202218,470,000 shares $231.80 million -0.4%N/A12.1 $12.55 10/15/202218,540,000 shares $210.99 million +2.2%N/A11.8 $11.38 9/30/202218,150,000 shares $222.16 million +5.3%N/A11 $12.24 9/15/202217,240,000 shares $277.74 million +3.4%N/A10.1 $16.11 8/31/202216,680,000 shares $245.20 million +2.7%N/A9.6 $14.70 8/15/202216,250,000 shares $299.98 million -3.1%N/A9.3 $18.46 7/31/202216,770,000 shares $266.81 million +2.4%N/A9.5 $15.91 7/15/202216,380,000 shares $245.54 million +7.0%N/A9.3 $14.99 6/30/202215,310,000 shares $181.12 million +4.7%N/A9 $11.83 6/15/202214,620,000 shares $153.95 million +1.3%N/A8.8 $10.53 5/31/202214,430,000 shares $164.36 million +10.2%N/A9.1 $11.39 5/15/202213,090,000 shares $155.38 million +3.7%N/A7.7 $11.87 4/30/202212,620,000 shares $167.09 million +0.9%N/A7.3 $13.24 4/15/202212,510,000 shares $208.54 million +1.8%N/A6.9 $16.67 3/31/202212,290,000 shares $233.76 million +4.0%N/A6.5 $19.02 3/15/202211,820,000 shares $176.24 million +3.2%N/A6.3 $14.91 2/28/202211,450,000 shares $196.02 million +3.1%N/A6.1 $17.12 2/15/202211,110,000 shares $184.98 million +1.3%N/A6.1 $16.65 1/31/202210,970,000 shares $208.87 million -3.2%N/A6.5 $19.04 1/15/202211,330,000 shares $250.39 million -0.6%N/A7.8 $22.10 12/31/202111,400,000 shares $302.67 million +5.3%N/A8.8 $26.55 12/15/202110,830,000 shares $324.25 million +9.7%N/A6.9 $29.94 11/30/20219,870,000 shares $322.35 million +3.5%N/A6.7 $32.66 11/15/20219,540,000 shares $343.34 million -4.3%N/A6.4 $35.99 10/29/20219,970,000 shares $366.10 million -1.9%N/A6 $36.72 10/15/202110,160,000 shares $386.28 million +47.3%N/A5.8 $38.02 9/30/20216,900,000 shares $283.45 million -1.4%N/A3.9 $41.08 9/15/20217,000,000 shares $422.10 million +3.4%N/A3.5 $60.30 8/31/20216,770,000 shares $430.50 million -9.7%N/A3.5 $63.59 8/13/20217,500,000 shares $469.95 million -11.7%N/A4 $62.66 7/30/20218,490,000 shares $355.39 million +1.9%N/A4.7 $41.86 7/15/20218,330,000 shares $349.78 million -20.1%12.3%5 $41.99 6/30/202110,430,000 shares $590.76 million +0.6%15.4%5.9 $56.64 6/15/202110,370,000 shares $363.99 million -2.4%15.3%8 $35.10 5/28/202110,620,000 shares $360.55 million +0.9%15.7%7.9 $33.95 5/14/202110,530,000 shares $330.64 million +1.0%N/A6.2 $31.40 4/30/202110,430,000 shares $389.77 million +1.8%N/A5.3 $37.37A new coin is elbowing its way to the top of the crypto world (Ad)With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … 4/15/202110,250,000 shares $425.68 million +0.4%N/A4.7 $41.53 3/31/202110,210,000 shares $413.51 million -3.8%N/A4.1 $40.50 3/15/202110,610,000 shares $491.03 million -6.2%N/A3.7 $46.28 2/26/202111,310,000 shares $506.24 million +14.9%N/A3.5 $44.76 2/12/20219,840,000 shares $562.55 million +9.1%N/A3.3 $57.17 1/29/20219,020,000 shares $551.39 million -5.1%N/A3.4 $61.13 1/15/20219,500,000 shares $721.24 million -3.9%N/A3.9 $75.92 12/31/20209,890,000 shares $756.59 million -9.2%N/A4.8 $76.50 12/15/202010,890,000 shares $669.63 million -1.5%N/A6.4 $61.49 11/30/202011,060,000 shares $346.62 million -1.7%N/A10.2 $31.34 11/15/202011,250,000 shares $328.84 million -0.4%N/A12.9 $29.23 10/30/202011,290,000 shares $370.26 million -0.1%N/A13.6 $32.80 10/15/202011,300,000 shares $363.41 million +7.9%N/A12.7 $32.16 9/30/202010,470,000 shares $293.79 million +7.5%N/A11.9 $28.06 9/15/20209,740,000 shares $310.71 million +6.2%N/A9.7 $31.90 8/31/20209,170,000 shares $323.06 million -0.7%N/A8.5 $35.23 8/14/20209,230,000 shares $322.31 million +4.5%N/A8.5 $34.92 7/31/20208,830,000 shares $259.25 million -0.5%N/A7.7 $29.36 7/15/20208,870,000 shares $289.34 million -5.6%N/A8.2 $32.62 6/30/20209,400,000 shares $278.05 million +3.5%N/A9 $29.58 6/15/20209,080,000 shares $262.78 million +9.3%N/A9.2 $28.94 5/29/20208,310,000 shares $224.95 million +0.7%N/A8.7 $27.07 5/15/20208,250,000 shares $216.81 million +2.0%N/A8 $26.28 4/30/20208,090,000 shares $187.04 million -1.0%N/A8.2 $23.12 4/15/20208,170,000 shares $184.07 million +5.3%N/A8.7 $22.53 3/31/20207,760,000 shares $194.08 million -8.9%N/A8 $25.01 3/13/20208,515,500 shares $188.45 million +4.1%N/A7.7 $22.13 2/28/20208,180,000 shares $160.16 million -5.4%N/A9.8 $19.58 2/14/20208,650,000 shares $187.79 million -3.2%N/A9.6 $21.71 1/31/20208,940,000 shares $200.35 million -1.2%N/A9.6 $22.41 EDIT Short Interest - Frequently Asked Questions What is Editas Medicine's current short interest? Short interest is the volume of Editas Medicine shares that have been sold short but have not yet been covered or closed out. As of January 15th, investors have sold 19,150,000 shares of EDIT short. Learn More on Editas Medicine's current short interest. What is a good short interest ratio for Editas Medicine? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDIT shares currently have a short interest ratio of 7.0. Learn More on Editas Medicine's short interest ratio. Which institutional investors are shorting Editas Medicine? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Editas Medicine: Wolverine Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Editas Medicine's short interest increasing or decreasing? Editas Medicine saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 19,150,000 shares, an increase of 5.2% from the previous total of 18,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Editas Medicine's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Editas Medicine: Organogenesis Holdings Inc. (16.20%), Sage Therapeutics, Inc. (11.65%), Eton Pharmaceuticals, Inc. (1.26%), PureTech Health plc (0.10%), Arcturus Therapeutics Holdings Inc. (20.50%), ChromaDex Co. (4.11%), SIGA Technologies, Inc. (8.38%), Annexon, Inc. (8.74%), Mereo BioPharma Group plc (4.64%), Compass Therapeutics, Inc. (3.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Editas Medicine stock? Short selling EDIT is an investing strategy that aims to generate trading profit from Editas Medicine as its price is falling. EDIT shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Editas Medicine? A short squeeze for Editas Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EDIT, which in turn drives the price of the stock up even further. How often is Editas Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDIT, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies Organogenesis Short Squeeze Sage Therapeutics Short Squeeze Eton Pharmaceuticals Short Squeeze PureTech Health Short Squeeze Arcturus Therapeutics Short Squeeze ChromaDex Short Squeeze SIGA Technologies Short Squeeze Annexon Short Squeeze Mereo BioPharma Group Short Squeeze Compass Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDIT) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
